These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3677009)

  • 1. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.
    Bartow SA; Pathak DR; Black WC; Key CR; Teaf SR
    Cancer; 1987 Dec; 60(11):2751-60. PubMed ID: 3677009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1997 May; 71(3):333-9. PubMed ID: 9139863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
    Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
    Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroadenoma of the breast: analysis of associated pathological entities--a different risk marker in different age groups for concurrent breast cancer.
    Shabtai M; Saavedra-Malinger P; Shabtai EL; Rosin D; Kuriansky J; Ravid-Megido M; Ben Haim M; Ayalon AH
    Isr Med Assoc J; 2001 Nov; 3(11):813-7. PubMed ID: 11729575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Histologic Spectrum of Apocrine Lesions of the Breast.
    Durham JR; Fechner RE
    Am J Clin Pathol; 2000 May; 113(suppl_1):S3-18. PubMed ID: 11993707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiographic microcalcification and parenchymal patterns as indicators of histologic "high-risk" benign breast disease.
    Bartow SA; Pathak DR; Mettler FA
    Cancer; 1990 Oct; 66(8):1721-5. PubMed ID: 2208027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pathologic study of benign breast diseases in Tokyo and New York.
    Schuerch C; Rosen PP; Hirota T; Itabashi M; Yamamoto H; Kinne DW; Beattie EJ
    Cancer; 1982 Nov; 50(9):1899-903. PubMed ID: 7116314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammotome biopsy under ultrasound control in the diagnostics and treatment of nodular breast lesions - own experience.
    Kibil W; Hodorowicz-Zaniewska D; Kulig J
    Pol Przegl Chir; 2012 May; 84(5):242-6. PubMed ID: 22763299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
    Marshall LM; Hunter DJ; Connolly JL; Schnitt SJ; Byrne C; London SJ; Colditz GA
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):297-301. PubMed ID: 9149887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of breast lesions associated with multiple papillomas.
    Ali-Fehmi R; Carolin K; Wallis T; Visscher DW
    Hum Pathol; 2003 Mar; 34(3):234-9. PubMed ID: 12673557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
    Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
    Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extra-tumoral breast tissue in breast-cancer patients: variations with a family history of breast cancer. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
    Aaman TB; Stalsberg H; Thomas DB
    Int J Cancer; 1998 Feb; 79(1):39-43. PubMed ID: 9495356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell turnover in apocrine metaplasia and apocrine adenosis of the breast.
    Elayat G; Selim AG; Wells CA
    Ann Diagn Pathol; 2010 Feb; 14(1):1-7. PubMed ID: 20123450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-operative breast pathology: apocrine lesions.
    Wells CA; El-Ayat GA
    J Clin Pathol; 2007 Dec; 60(12):1313-20. PubMed ID: 18042688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary apocrine change of the breast: associations with atypical hyperplasia and risk of breast cancer.
    Page DL; Dupont WD; Jensen RA
    Cancer Epidemiol Biomarkers Prev; 1996 Jan; 5(1):29-32. PubMed ID: 8770463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD; Ashton M; Lefkowitz M
    Cancer; 1996 Jun; 77(12):2529-37. PubMed ID: 8640702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
    Wellings SR; Jensen HM; Marcum RG
    J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 Immunohistochemical Expression in Apocrine Lesions of the Breast.
    Kővári B; Báthori Á; Cserni G
    Pathobiology; 2015; 82(6):259-63. PubMed ID: 26562027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.